IP Verse

Use Of Cannabinoids In The Treatment Of Epilepsy - EP3743053

The patent EP3743053 was granted to GW Research on Nov 29, 2023. The application was originally filed on Jan 22, 2019 under application number EP19702670A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3743053

GW RESEARCH
Application Number
EP19702670A
Filing Date
Jan 22, 2019
Status
Granted And Under Opposition
Oct 27, 2023
Grant Date
Nov 29, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

KRAUS & LEDERER PARTGMBBAug 27, 2024KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONGB2539472
INTERNATIONAL-SEARCH-REPORTUS2017181982
INTERNATIONAL-SEARCH-REPORTWO2016059403
OPPOSITIONGB2539472
OPPOSITIONWO2015193668

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) ", ClinicalTrials.gov; NCT02091375, (20160927), ClinicalTrials.gov; NCT02091375, URL: https://clinicaltrials.gov/study/NCT02091375?term=NCT02091375&rank=1&a=18, XP093210514-
OPPOSITION- Anonymous, "Public summary of opinion on orphan designation - Cannabidiol for the treatment of Dravet syndrome", European Medicines Agency; EMA/COMP/557465/2014; Committee for Orphan Medicinal Products, (20141110), European Medicines Agency; EMA/COMP/557465/2014; Committee for Orphan Medicinal Products, URL: https://www.ema.europa.eu/en/documents/orphan-designation/eu3141339-public-summary-opinion-orphan-designation-cannabidiol-treatment-dravet-syndrome_en.pdf, XP093210517-
OPPOSITION- S. WRIGHT ET AL., "CANNABIDIOL (CBD) IN DRAVET SYNDROME: A RANDOMISED, DOSE-RANGING PHARMACOKINETICS AND SAFETY TRIAL (GWPCARE1)", EPILEPSIA, (20170901), vol. 58(Suppl.5), page s56, XP002790754-
OPPOSITION- Vezyroglou Katharina; Cross J. Helen, "Targeted Treatment in Childhood Epilepsy Syndromes", Current Treatment Options in Neurology, Springer US, New York, New York, (20160507), vol. 18, no. 6, doi:10.1007/s11940-016-0407-4, ISSN 1092-8480, pages 1 - 12, XP035680313
OPPOSITION- Wallace Adam, Wirrell Elaine, Kenney-Jung Daniel L., "Pharmacotherapy for Dravet Syndrome", PAEDIATRIC DRUGS, ADIS INTERNATIONAL, AUCKLAND, NZ, NZ , (20160601), vol. 18, no. 3, doi:10.1007/s40272-016-0171-7, ISSN 1174-5878, pages 197 - 208, XP009557384
OPPOSITION- Wirrell Elaine C., "Treatment of Dravet Syndrome", CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, WINNIPEG, CA, CA , (20160601), vol. 43, no. S3, doi:10.1017/cjn.2016.249, ISSN 0317-1671, pages S13 - S18, XP093210510
OPPOSITION- Orrin Devinsky, J. Helen Cross, Linda Laux, Eric Marsh, Ian Miller, Rima Nabbout, Ingrid E. Scheffer, Elizabeth A. Thiele, Stephen Wright, "Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome", The New England journal of medicine, Massachusetts Medical Society, US, US , (20170525), vol. 376, no. 21, doi:10.1056/NEJMoa1611618, ISSN 0028-4793, pages 2011 - 2020, XP055581640
OPPOSITION- Charlotte Dravet, "The core Dravet syndrome phenotype", Epilepsia, Raven press LTD, New York , US, New York , US , (20110401), vol. 52, doi:10.1111/j.1528-1167.2011.02994.x, ISSN 0013-9580, pages 3 - 9, XP055735374
OPPOSITION- Emilio Perucca, "Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?", Journal of Epilepsy Research, (20171228), vol. 7, no. 2, doi:10.14581/jer.17012, ISSN 2233-6249, pages 61 - 76, XP055581907

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents